Supply chain resilience strategies: the case of pharmaceutical firms in Morocco

The current environment is featured by disruptions such as fluctuations in demand, risks of relations with suppliers,…. Accordingly, the company needs resilience to alleviate these risks and continue operating its activities through main strategies that are underlined broadly by recent researches such as flexibility, redundancy and agility. This research aims to minimize the dearth of empirical researches in the realm of supply chain resilience strategies by investigating empirically the proactive and reactive strategies that improve resilience in pharmaceutical firms. In this research, the supply chain resilience strategies are basically related to. An empirical study was conducted in 33 the pharmaceutical firms. Afterwards, the response rates of participants were calculated for each of the supply chain resilience strategies (in “very great extent”). Accordingly, the results demonstrated that most of the strategies related to supply flexibility, demand flexibility, redundancy and the supply chain risk management process are applied very frequently. However, the strategies formulating the production flexibility are applied frequently (very extent) but not very intensively (not in “very great extent”). On the other side, these strategies aim to achieve resilience through proactive or reactive ability. Then, the analysis of results demonstrates that a large part of supply chain resilience strategies used by pharmaceutical firms are proactive and appertain to all elements of supply chain resilience (supply flexibility, demand flexibility, ….)